premature ovarian failure (Coulam and Ryan, 1979; Elder et al., 1981; Damewood et al., 1986; Pekonen et al., 1986 ; Premature menopause and unexplained infertility are Ahonen et al., 1987; Miyake et al., 1987; , associated with ovarian antibodies, a marker of ovarian 1989; Moncayo-Naveda et al., 1989; Bannatyne et al., 1990 ; autoimmunity. In premature menopause, FSH is also elev- Luborsky et al., 1990; Muechler et al., 1991; Fenichel et al. , ated while in unexplained infertility FSH concentrations 1997).
are often normal. The relationship of ovarian antibodies
Unexplained infertility is also associated with ovarian autoand FSH and inhibin B, as markers of follicle function, was immunity (Dunbar, 1989; ; Luborsky investigated in unexplained infertility. Ovarian antibodies et al., 1990; Meyer et al., 1990 ; Barbarino-Monnier et al., were determined by immunoassay in comparison to 1991; Gobert et al., 1992; Hovav et al., 1994 ; Narayanan normal controls (n ⍧ 12); 51.9% were positive at two SD et al., 1995; Geva et al., 1996b; Luborsky et al., 1999a ). (P < 0.05) and 38.5% were positive at three SD above the Since ovarian antibodies are associated with elevated FSH in control mean (P < 0.01). In this study three SD above the premature menopause, the expectation was that in unexplained control mean was considered positive. In unexplained infertility, ovarian antibodies (evidence of autoimmunity) infertility, three out of 10 (30%) had elevated day 3 FSH would be associated with elevated FSH. In previous studies it (>10 mIU/ml) and ovarian antibodies, while 17/42 (40%) was noted that women with unexplained infertility and ovarian had normal FSH (<10 mIU/ml) and ovarian antibodies. In antibodies had normal day 3 FSH concentrations (Wheatcroft women with normal FSH, two out of seven (29%) had et al., 1997; Luborsky et al., 1999a) . In contrast, Ahmed low inhibin B concentrations (<33 pg/ml) and ovarian Ebbiary reported that regularly cycling infertile women with antibodies, and 15/35 (43%) had normal inhibin B concenelevated FSH had more autoantibodies than those with low trations (> 33 pg/ml) and ovarian antibodies. Similarly, FSH and only women with elevated FSH concentrations had when women with and without ovarian antibodies were ovarian antibodies (Ahmed Ebbiary et al., 1994) .
compared there was no difference in mean FSH or mean
There is relatively little information on the relationship of inhibin B concentrations. Thus, unlike other endocrine ovarian antibodies and markers of ovarian function. Two autoimmune disorders, hormone concentrations are not previous studies of FSH concentrations and ovarian antibodies, predictors of potential ovarian autoimmunity. This suggests do not agree (Ahmed Ebbiary, et al., 1994; Wheatcroft et al. , that in unexplained infertility ovarian antibodies are an
Introduction
Materials and methods An altered concentration of regulatory hormone or an endorgan secretory product is usually the first indication of Subjects a potential autoimmune endocrine disease (Drexhage and
The study groups consisted of women with unexplained infertility Wulffraat, 1994; Baker, 1997) . Ovarian autoimmunity is associ-(n ϭ 52) entering the clinic for evaluation or treatment in December 1997 and between March and May of 1998. Within the study group, 33 women were initiating an IVF cycle and 19 were undergoing a baseline evaluation prior to ovulation induction (no IVF). Relevant *This work was presented in part at the XIIth Ovarian Workshop, August 5-7, 1998, in Houston, Texas, USA.
diagnostic and treatment information, including peak oestradiol (day of HCG) concentrations during ovulation induction, was obtained P Ͻ 0.0001). All sera were tested at a dilution of 1:100, except when the titre was assessed. The captured autoantibodies were identified from patient records. Women with polycystic ovarian syndrome (PCOS) were excluded based on a history of oligomenorrhoea (menses by a goat anti-human immunoglobulin (Ig)G-alkaline phosphatase conjugate (FAB specific; Sigma, St Louis, MO, USA). Bound alkaline interval of Ͼ42 days) and ultrasound evidence of cystic ovary (Franks, 1989) . Women with recurrent fetal loss were excluded based phosphatase (AP) was reacted with AP substrate (Sigma) and the product read at 405 nm (Thermomax; Molecular Devices, Sunnyvale, on a history of more than three unexplained spontaneous abortions. Unexplained infertility patients had normal results on standard clinical CA, USA). evaluation. The evaluation criteria included: (i) inability to conceive for ജ1 year during unprotected intercourse; (ii) normal semen FSH and inhibin B measurement analysis, postcoital test, ovulation (luteal phase progesterone) and FSH concentrations were measured by a chemiluminescence immunotubal patency. All patients had a hysterosalpingogram performed to assay (Chiron; Bayer, Tarrytown, NY, USA). The normal range for ensure tubal patency. If indicated (dysmenorrhoea, pelvic pain, or an day 3 FSH was 2.5-10.2 mIU/ml (95% confidence interval). The abnormal hysterosalpingography), a laparoscopy was performed. In sensitivity of the assay was 0.3 mIU/ml and the inter-assay and intrathe study group only two had a laparoscopy. In addition, some were assay coefficients of variation were 1.7 and 4.5% respectively. In this previously treated for endometriosis (n ϭ 10), tubal block (n ϭ 4) study values for normal FSH were those below 10 mIU/ml. Inhibin B or uterine fibroids (n ϭ 2). Although endometriosis is often associated was measured by enzyme immunoassay (Serotec; Harlan Bioproducts, with infertility, the cause and effect relationship between the two Indianapolis, IN, USA). The mean range for day 3 inhibin B was conditions has not yet been discerned. Previously, we found no 33-45 pg/ml (95% confidence interval). Values above 33 pg/ml were relationship between endometriosis and ovarian antibodies (Luborsky considered normal for inhibin B in this study. et al., 1999a) , hence, these women were not excluded from this analysis. Details of the study group are summarized in Table I . The Statistical analysis protocol was reviewed and approved by the Institutional Review For measurement of ovarian antibody, samples were assessed in Board.
duplicate against the control samples and a positive control. InterTwo types of controls without diagnosed infertility were used in assay and intra-assay coefficients of variation for specific OD signals the study: (i) sera from normally cycling women 18-50 years old were Ͻ15 and 10% respectively. The inter-assay and intra-assay (n ϭ 12) were used as assay controls (mean FSH concentration 10.8 coefficients of variation based on positive/negative values were Ͻ5%. Ϯ 1.2 mIU/ml; range, 6.9-19.0 mIU/ml), and (ii) blind control sera
In this study positive values were those Ͼ3 SD (P Ͻ 0.01) above from normally cycling women (n ϭ 4) (mean age 28 years), the control mean. To compare OD values directly, OD values were menopausal women (n ϭ 7) (mean age 52 years) and men (n ϭ 3) normalized between plates against a positive control serum used in included in the blinded study group.
all assays: where normalized value ϭ (OD test sample/OD positive control in same plate)ϫ(expected OD from same positive control in Antibody tests first plate). Blood was collected into a red top tube, and the serum separated and Power analysis estimate for ovarian antibodies between normal stored at -20°C. The study group and controls of group 2 were coded FSH and increased FSH was 80%. Results were analysed by χ 2 test, as a single group and tested blind. Ovarian antibodies were detected paired Students t-test or one-way analysis of variance with individual by enzyme-linked immunosorbent assay (ELISA) (Luborsky et al., comparisons by the least significant difference method, as appropriate. 1990; Meyer et al., 1990 ) with a capture antigen composed of a pool P Ͻ 0.05 was considered to be statistically significant. Statistical of fractionated extracts (1000-10 000 g pellet) from three to five rat analysis was carried out using the Statistical Package for the Social ovaries (Asare et al., 1989; Luborsky et al., 1990 Luborsky et al., , 1999a Meyer Sciences (SPSS, Chicago, IL, USA) or Excel statistical software. et al., 1990) . Rat ovaries were synchronized and ovulation was stimulated by treatment of immature rats (CD strain) by a standard protocol of pregnant mare's serum gonadotrophin (50 IU, day 26)
Results
and HCG (25 IU, day 28) (Dorflinger et al., 1983; In the study group the average age, years of infertility, gravidity, 1984; Meyer et al., 1990) . Ovaries were removed on day 2 after parity, number of prior intrauterine inseminations (IUI) or IVF HCG. The results (based on optical density; OD) with rat and human ovary were highly correlated (correlation coefficient ϭ 0.98, cycles were not significantly different for those with normal Ovarian antibody positive (POS) sera were identified by comparison to control sera (see methods). FSH and inhibin B were negatively correlated (solid regression line, R 2 ϭ 0.6; P ϭ 0.00003) as expected. The samples positive for ovarian antibody (e) were distributed across all hormone concentrations. NEG ϭ negative.
(ഛ10 mIU/ml) or elevated (Ͼ10 mIU/ml) FSH. The general features of the study group are summarized in Table I . The average FSH concentration was different between normal and elevated FSH (6.3 Ϯ 1.9 and 15.8 Ϯ 4.7 mIU/ml respectively, P ϭ 0.019). The average inhibin B concentration was different 1079 Ϯ 641 and 973 Ϯ 722 pg/ml respectively, P ϭ 0.74).
In the study group, 20/52 (38.5%) were positive for ovarian of correlation between hormone concentration and ovarian antibodies based on a threshold value of three SD above the antibodies. control mean value (P Ͻ 0.01). At two SD above the control In the first analysis, an estimated threshold value for FSH mean 27/52 (51.9%) (PϽ0.05) were positive, similar to the of 10 mIU/ml was used to designate 'elevated' or 'normal' prevalence reported previously (Luborsky, 1999a) . The more FSH groups. Likewise, the threshold value of 33 pg/ml for stringent threshold value of three SD above the control mean inhibin B was based on the lower limit of the normal range was used in this study. The blinded controls (n ϭ 14) were defined by the immunoassay kit. In order to determine whether negative for ovarian antibodies with the exception of these threshold values were appropriate and whether there 2/7 (28.5%) women in menopause. Ten women with infertility were differences in the FSH or inhibin B concentrations by had elevated FSH concentrations (Ͼ10 mIU/ml), and 42 had ovarian antibody result, women were grouped by ovarian normal FSH concentrations (ഛ10 mIU/ml). Of women with antibody result (Figure 2 ). The mean FSH value was elevated FSH concentrations three out of 10 (30.0%) had~8 mIU/ml and was similar but slightly lower than the empirical ovarian antibodies, and 17 out of 42 (40.4%) women with value of 10 mIU/ml used to separate the study group by FSH normal FSH had ovarian antibodies (not significantly different).
concentrations. The mean inhibin B value was~55 pg/ml and Of the 42 women with normal FSH concentrations, seven had was higher than the empirical value used to separate the study low inhibin B concentrations (Ͻ33 pg/ml) and 35 had normal group by inhibin B concentrations. Nonetheless, there was no inhibin B concentrations. In women with low inhibin B difference in the mean FSH concentration (8.5 versus concentrations, two out of seven (28.5%) had ovarian anti-8.0 mIU/ml respectively) or the mean inhibin B concentration bodies. In women with normal FSH and normal inhibin B (54.7 versus 54.5 mIU/ml) for women with or without ovarian concentrations, 15 out of 35 (42.9%) had ovarian antibodies.
antibodies. There was also no difference in the mean FSH or When the ovarian antibody results were examined as a function inhibin B concentration when only women with normal FSH of both FSH and inhibin B, they were distributed across the concentrations were assessed according to the presence or absence of ovarian antibodies. range of hormone values (Figure 1 ), consistent with a lack
Discussion
with FSH concentration in women with unexplained infertility (Wheatcroft et al., 1997) . Significantly they also found evidence The results of this study show that ovarian antibodies are not of complement activation which was greatest in the elevated correlated with FSH or inhibin B concentrations. A significant FSH group, and also significant in the normal FSH group but number of women with both normal FSH and inhibin B had not in controls. ovarian antibodies. This is the first study that also shows that How can FSH and inhibin B values be normal in the face ovarian antibodies are found in individuals with normal inhibin of a potential autoimmune disease? In animal models and B. Thus unlike other endocrine autoimmune diseases, concenhuman premature menopause, lymphocytic infiltration is seen trations of ovarian regulatory hormones are not a predictor for in maturing but not primordial or primary follicles (Coulam ovarian autoimmunity in infertility.
et al., 1981; Sedmak et al., 1987; Tung et al., 1987a,b ; Tung It has previously been shown that ovarian antibodies are and Teuscher, 1995). Since only some follicles may be subject associated with premature menopause and unexplained infertilto an autoimmune reaction in early stages of the disorder, the ity (Luborsky et al., 1990 (Luborsky et al., , 1999a . In contrast, ovarian antibodendocrine function of remaining follicles may contribute to ies were not significantly associated with PCOS in women the apparently normal concentrations of serum hormones. This with a normal body mass index (Luborsky et al., 1999a) , or is consistent with the report that normal ovarian function with recurrent spontaneous fetal loss (McKenna et al., 1999) is compatible with severe ovarian inflammation in murine or a variety of control groups.
autoimmune ovarian disease (Bagavant et al., 1999) . Complete A number of investigators showed an association between lack of function may not occur until there is significant disease infertility and ovarian antibodies Meyer progression or depletion of the follicle pool. Barbarino-Monnier et al., 1991; Ahmed Ebbiary Similarly, during the progression to spontaneous menopause et Geva et al., 1994 Geva et al., , 1996a Hovav et al., 1994;  that occurs at~50 years of age, altered hormone concentrations Narayanan et al., 1995; Nip et al., 1995) . There also appears precede the loss of menstrual cycles. In spontaneous menoto be a relationship of ovarian antibodies to poorer outcomes pause, the progression to ovarian failure occurs over a period of infertility treatment (Meyer et al., 1990; Hovav et al., of 4-5 years (World Health Organization, 1996) . During 1994; Narayanan et al., 1995; Geva et al., 1996a) and with this transition, hormone concentrations become erratic and lower pregnancy rates (Geva et al., 1996a; irregular. Inhibin B, a direct product of the maturing follicle, Pong, 2000) .
is an earlier endocrine marker than FSH of reproductive decline In addition, it has been suggested that there is an association (Prior, 1998; Welt et al., 1999) . Likewise women with normal of ovarian antibodies with a subgroup of PCOS (van Gelderen early follicular phase FSH who did not respond to stimulation et al., 1993; Fenichel et al., 1999) . However there are other with human menopausal gonadotrophin (HMG), developed reports that suggest PCOS is not associated with ovarian elevated FSH concentrations within 1 year, indicating that antibodies (Rojansky et al., 1997; Luborsky et al., 1999b) .
FSH was not predictive of potential ovarian failure (Farhi The apparent lack of agreement regarding PCOS may be due et al., 1997). the heterogeneity of PCOS and differences in patient selection,
The progression of autoimmune diseases also occurs over a or differences in the antibody tests and the antigens detected.
prolonged time period. Autoantibodies may appear before the Overall, there appears to be general agreement on the associonset of clinical symptoms. For example, the risk of thyroidation of unexplained infertility with ovarian antibodies.
itis is higher in healthy individuals with thyroid antibodies The question then becomes whether altered reproductive (Mariotti et al., 1995; Massoudi et al., 1995) . Similarly, endocrine markers of ovarian function are associated with autoantibodies associated with diabetes, e.g. GAD65 and evidence of ovarian autoimmunity, or, if ovarian autoimmunity IA-2 antibodies, predict future insulin dependence and may is evident in women with normal concentrations of reproductive appear months or years before clinical diagnosis (Gottsater endocrine markers. In an earlier study (Ahmed Ebbiary et al., et al., 1995; Ivarsson et al., 1997; Bonifacio et al., 1999) . 1994), this question was addressed and immunofluorescence Premature menopause eventually developed in patients with was used to detect a variety of autoantibodies including polyglandular disease type I and with adrenal and steroid cell ovarian autoantibodies. In this study, 27% of individuals with antibodies who were followed for 8 years (Coulam and Lufkin, normal FSH and 58% of individuals with elevated FSH 1981; Ahonen et al., 1987) . (Ͼ10 mIU/ml) had at least one antibody. However, ovarian
In addition to ovarian antibodies, the most frequently antibodies (6%) were only found in the elevated FSH group. studied autoantibodies have been the antiphospholipid antiSince immunofluorescence is subjective and sections of ovary bodies (APA) (Birkenfeld et al., 1994; Geva et al., 1994 ; may have a variable content of specific antigens and relevant Gleicher et al., 1994; Sher et al., 1994; Dmowski et al. , follicular structure, it is not surprising that few women with 1995; Birdsall et al., 1996; Roussev et al., 1996 ; Coulam ovarian antibodies were found. In comparing immunoassay et al., 1997; Kutteh et al., 1997; Battaglia et al., 1998) . and immunohistochemical detection of ovarian antibodies, it
The presence of circulating APA associated with unexplained was found that sections from different ovaries sometimes infertility is a syndrome known as reproductive autoimmune produced different immunohistochemical results (Meyer et al., failure syndrome (RAFS) (Gleicher and El-Roeiy, 1988 ). 1990). The results of the current study agree with those of
The mechanisms by which APA are associated with Wheatcroft et al. who reported that ovarian, thyroid, endometunexplained infertility are not completely known. Targets for a direct effect of APA include endothelial cells (Roubey rial and several non-organ specific antibodies did not differ Battaglia, C., Sgarbi, L., Salvatori, M. et al. (1998) Increased anticardiolipin and Hoffman, 1997), trophoblastic cells (Rote et al., 1998;  antibodies are positively related to the uterine artery pulsatility index in Di Simone et al., 1999) , and pre-embryos (Kaider et al., unexplained infertility. Hum. Reprod., 13, 3487-3491. 1999 ). The actions of APA on endothelial cells result in Birdsall, M., Lockwood, G., Ledger, W. et al. (1996) thrombotic activation (Roubey et al., 1997) . These actions
Bonifacio, E., Scirpoli, M., Kredel, K. et al. (1999) hormones would be maintained. Eventually, cellular destruction Farhi, J., Homburg, R., Ferber, A. et al. (1997) Non-response to ovarian proceeds, the pool of healthy follicles is reduced and ovarian stimulation in normogonadotrophic, normogonadal women: a clinical sign of impending onset of ovarian failure pre-empting the rise in basal follicle failure occurs.
stimulating hormone levels. Hum. Reprod., 12, 241-243. Fenichel, P., Sosset, C., Barbarino-Monnier, P. et al. (1997) Prevalence,
